Pancreatic enzyme replacement therapy for steatorrhoea in pancreatic cancer

Journal List Cochrane Database Syst Rev PMC6491113 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice Cochrane Database Syst Rev. 2018; 2018(2): CD012952. Published online 2018 Feb 12. doi:10.1002/14651858.CD012952PMCID: PMC6491113Yazan H Nofal, Yaser Abu Dail, Yazan Assaf, Hayan Abo Samra, Fatima Abbas, Ammar Hamzeh, and Nahla Alhaj HasanAuthor information Copyright and License information PMC DisclaimerAbstractThis is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To evaluate the efficacy of PERT for the treatment of steatorrhoea in people with pancreatic cancer by accessing whether it:reduces the severity and duration of common symptoms, including fatty (greasy or oily appearance and residue), foul‐smelling, pale‐coloured, and heavy stools (bulky and difficul...